January 8, 2026 90-day analysis Get alerts for kariusdx.com

Summary: Karius launches Karius Focus | BAL lung test

Why It Matters: The company is expanding from general blood-based testing into specialized lung infection diagnostics. This new test targets a specific clinical sample type (BAL fluid) to help doctors identify pneumonia in high-risk patients.

What Changed:

  • Launched Karius Focus | BAL, a new metagenomic test for lung infections.
  • Added a "Clinical Resources" section featuring publications, grants, and medical education.
  • Updated the homepage to highlight the detection of over 500 pathogens in lung fluid and 1,000 pathogens in blood.
  • Replaced the "Clinical Evidence" and "Clinical Data" menu items with a broader "Clinical Resources" category.
  • Added a news section featuring a "Top 25 Biotech Companies of 2025" award and a "Top Workplace" recognition.
Track companies like kariusdx.com
Get actionable insights on price changes, product launches, positioning shifts and more
Start Tracking →